|
Keynote Speakers
Dr. Peter Sorger, Prof. of Biological Engineering, MIT
Dr. James Collins, Prof. of Biomedical Engineering,
Boston University
and speakers from
Cell Signaling Technology, Broad Institute, Genstruct,
GE Global Research Center, BG Medicine, Stanford
University
Panel discussion: Integrating
modeling into drug discovery
with representatives from
Pfizer, Astra-Zeneca, Sanofi-Aventis, Novartis and
Vertex
Final Program
|
7:30 |
Registration and light breakfast |
|
|
8:15 |
Opening remarks |
Brian Hare |
|
8:30 |
Keynote Speaker: "Harnessing gene networks
in drug discovery" |
Dr. James Collins, Boston University |
|
9:30 |
"Identification of activated tyrosine
kinases in human cancer using PhosphoScan®
technology" |
Dr. Roberto Polakiewicz, Cell Signaling
Technology |
|
10:00 |
"Gene expression based high throughput
screening and its application to
cancer" |
Dr. Ken Ross, Broad Institute |
|
10:30 |
"A systems biology approach for
understanding of mechanisms of drug-induced
vascular injury" |
Dr. Keith Elliston, Genstruct |
|
11:00 |
Break |
|
11:15 |
Panel discussion: Integrating Modeling into Drug
Discovery
|
Moderator: Carolyn Cho
- Dr. David de Graaf, Pfizer
- Dr. Alan Buckler, Novartis
- Dr. Mike Briggs, Vertex
- Dr. Jack Beusmans, AstraZeneca R&D
Boston
- Dr. Jack Pollard, Sanofi-Aventis
|
|
12:30 |
Lunch |
|
1:30 |
"Integrating modeling into imaging agent
development" |
Dr. Brion Sarachan, Global Research Center |
|
2:00 |
"Integrated correlation networks for
systems pathology & systems
pharmacology" |
Dr. Tom Plasterer, BG Medicine |
|
2:30 |
"Human cell systems biology for chemical
genomics and drug discovery: taking advantage of
complexity in cellular models of
disease" |
Dr. Eugene Butcher, Stanford University |
|
3:00 |
Keynote Speaker: "Systems pharmacology and
anti-cancer therapy" |
Dr. Peter Sorger, MIT |
PhosphoScan is a
registered trademark of Cell Signaling Technology, Inc.
Sponsors
|
